X-18647303-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.214G>A(p.Glu72Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000455 in 1,097,695 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.214G>A | p.Glu72Lys | missense_variant | Exon 4 of 6 | ENST00000379984.4 | NP_000321.1 | |
RS1 | XM_047442337.1 | c.118G>A | p.Glu40Lys | missense_variant | Exon 2 of 4 | XP_047298293.1 | ||
CDKL5 | NM_001037343.2 | c.2797+1213C>T | intron_variant | Intron 20 of 21 | NP_001032420.1 | |||
CDKL5 | NM_003159.3 | c.2797+1213C>T | intron_variant | Intron 19 of 20 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.214G>A | p.Glu72Lys | missense_variant | Exon 4 of 6 | 1 | NM_000330.4 | ENSP00000369320.3 | ||
CDKL5 | ENST00000379989.6 | c.2797+1213C>T | intron_variant | Intron 20 of 21 | 1 | ENSP00000369325.3 | ||||
CDKL5 | ENST00000379996.7 | c.2797+1213C>T | intron_variant | Intron 19 of 20 | 1 | ENSP00000369332.3 | ||||
RS1 | ENST00000476595.1 | n.705G>A | non_coding_transcript_exon_variant | Exon 3 of 5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183440Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67872
GnomAD4 exome AF: 0.00000455 AC: 5AN: 1097695Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 1AN XY: 363121
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Juvenile retinoschisis Pathogenic:7
xperimental studies have shown that this missense change affects RS1 function (PS3, PMID: 20809529;20061330). REVEL score is 0.921 (PP3_mod). This variant is located in a mutational hotspot where >50% of variants are pathogenic (PM1) Other changes at this amino acid residue have been classified as pathogenic (PM5, p.Glu72Gln; p.Glu72Val; p.Glu72Lys; p.Glu72Gly). RS1 mutations are specific to retinoschisis phenotypes (PP4) -
NM_000330.3(RS1):c.214G>A(E72K) is classified as pathogenic in the context of X-linked juvenile retinoschisis. Sources cited for classification include the following: PMID 20061330, 10922205, 618178, 19390641, 10533068, 10234514 and 20809529. Classification of NM_000330.3(RS1):c.214G>A(E72K) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. -
- -
- -
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM5,PP2,PP3,PP4. This variant was detected in hemizygous state. -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.92; 3Cnet: 0.96). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009888 /PMID: 9618178). Different missense changes at the same codon (p.Glu72Asp, p.Glu72Gln, p.Glu72Gly, p.Glu72Val) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009889, VCV000098916, VCV000992968, VCV001994509 /PMID: 11295123, 17631851, 28272453, 9618178). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Criteria applied: PS3,PS4,PM5_STR,PM2_SUP,PP3,PP4 -
not provided Pathogenic:6Other:1
- -
- -
- -
- -
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 72 of the RS1 protein (p.Glu72Lys). This variant is present in population databases (rs104894928, gnomAD 0.01%). This missense change has been observed in individuals with X-linked retinoschisis (PMID: 9618178, 28272453, 30652005). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9888). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RS1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RS1 function (PMID: 20809529). This variant disrupts the p.Glu72 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9618178, 28272453). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
RS1: PS4, PM1, PM2, PM5, PP3, PP4 -
Published functional studies demonstrate a damaging effect with misfolding of the discoidin domain, which results in the formation of high molecular mass aggregates in the cell (Vijayasarathy et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10234514, 31087526, 20809529, 20061330, 27788217, 23288992, 22245536, 19324861, 22245991, 29081674, 27798099, 9618178, 30652005, 33781268, 33460243) -
Retinal dystrophy Pathogenic:2
- -
- -
Inborn genetic diseases Pathogenic:1
The c.214G>A (p.E72K) alteration is located in exon 4 (coding exon 4) of the RS1 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the glutamic acid (E) at amino acid position 72 to be replaced by a lysine (K). Based on data from gnomAD, the A allele has an overall frequency of 0.001% (2/183440) total alleles studied. The highest observed frequency was 0.006% (1/16007) of European (Finnish) alleles. This variant is a common founder mutation and has been detected in individuals with X-linked juvenile retinoschisis (The Retinoschisis Consortium, 1998; Hiriyanna, 1999; Huopaniemi, 1999; Eksandh, 2000; Riveiro-Alvarez, 2009; Kim, 2009; Skorczyk, 2012; Wang, 2016; Hu, 2017; Sudha, 2018; Avela, 2019; Kondo, 2019; Huang, 2020; Bai, 2021; Hahn, 2022; Bender, 2022). This amino acid position is highly conserved in available vertebrate species. Functional and structural analysis suggest this alteration disrupts the local structure, but does not significantly impair secretion of the mutant protein (Wu, 2003; Sergeev, 2010; Vijayasarathy, 2010). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at